Bio-One Receives $30 Million Investment Commitment.

Business Editors/Health/Medical Writers

ORLANDO, Fla.--(BUSINESS WIRE)--April 16, 2003

Bio-One Corporation (OTCBB:BICO) ("Bio-One" or the "Company") and Famco Acquisitions Company, LLC have signed an agreement for Famco to provide an equity investment totaling $30,000,000. Famco has agreed to pay $1.00 per share for convertible preferred stock with a 10% coupon. The agreement also provides for certain lockup provisions at the time of conversion from preferred to common. Famco Acquisitions Company, LLC is a private equity fund that provides early stage and follow-on capital for emerging growth companies that have assembled exceptional management teams. Within the next 30 days Bio-One anticipates the availability of these funds and the $15 million debt financing announced in January. The funds will be allocated for closing on a series of acquisitions with annual revenues of approximately $60 million and EBITDA of approximately $8 to $9 million. Armand Dauplaise, the Bio-One President and CEO states that "this capital and the closing on these acquisitions will facilitate the Company's American Stock Exchange application which is anticipated to be submitted during the second quarter. Famco has also expressed an interest in providing additional equity capital to support rapid growth."

Business Summary

Bio-One Corporation is an emerging growth company that is embarking on building a significant business in the nutritional supplements industry via vertical integration acquisitions and marketing consolidation in Florida and the Southeast. The Company's home state, Florida, ranks second only to California in nutritional supplement sales and ranks first nationally in per capita consumption. The Company's goal is threefold; 1) to uniquely serve people worldwide who desire vitality and longevity; 2) to interface a quality and value growth philosophy through vertical integration and selected marketing companies consolidation; 3) to provide an outstanding return on investment for Company shareholders.

Certain statements released by Bio-One Corporation that are forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Editors and investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the Company's business prospects and performance. These include, but are not limited to, economic, competitive, governmental, technological and other risks detailed in the company's registration statements and periodic reports filed with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.